Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report

doi:10.12998/wjcc.v10.i17.5708

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3997)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

298

WORD

HTML

2312

Figures (1-5)

435

Sum=3113

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

221

Download

633

Sum=854

Jun 16, 2022 (publication date) through Jan 2, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jun 16, 2022; 10(17): 5708-5716
Published online Jun 16, 2022. doi: 10.12998/wjcc.v10.i17.5708

Full Size Figure Download Figure

Figure 5 Programmed cell death protein ligand 1 expression by lymphoma cells. Scattered large lymphoma cells, but not nonlymphoma cells, were strongly positive for programmed cell death protein ligand 1 (clone SP142) (× 200). Insert: Positive staining of the large lymphoma cell membrane was observed (× 400).

Citation: Hojo N, Nagasaki M, Mihara Y. Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report. World J Clin Cases 2022; 10(17): 5708-5716
URL: https://www.wjgnet.com/2307-8960/full/v10/i17/5708.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i17.5708